# Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule

> **NCT01242618** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 5 (actual)

## Conditions studied

- Skin Carcinoma

## Interventions

- **BIOLOGICAL:** engineered nasal cartilage graft

## Key facts

- **NCT ID:** NCT01242618
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242618, "Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01242618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*